Albumin 20% is the gold standard of natural colloidals Albumin's profile of the safety and efficacy exceeds synthetic colloids in volume resuscitation of critically ill patients Quality, purity, and safety of Albumin-Biopharma correspond with the European Pharmacopoeia regulations for the finished product and raw materials Conditions in which albumin is indicated: shock (hemorrhagic, traumatic, thermal); acute hemorrhage; purulent-septic conditions; liver diseases with violation of albumin-synthesizing function; kidney diseases (nephritis, nephrotic syndrome); the burn disease; surgeries with using of artificial circulation; therapeutic plasmapheresis; hemolytic disease of newborns (HDN); preoperative hemodilution; cerebral edema; gastrointestinal disorders with impaired function of intestinal absorption or intestinal permeability